The US government should spend at least $15 billion over the next five years to unlock private capital and investment in the biotechnology sector to blunt China’s rapid surge in the field, a biotechnology commission said Tuesday.
The congressionally-mandated National Security Commission on Emerging Biotechnology made the recommendations in its final report.
“China is quickly ascending to biotechnology dominance, having made biotechnology a strategic priority for 20 years,” the commission, led by Sen.